Explore the Agenda
일정 확인하기
8:30 am Check-In & Morning Coffee
Workshop A – Drug Delivery
9:30 am Harnessing Selective Nanoparticle Technologies to Achieve Scalable, Specific, & Selective Delivery
As lipid-based nanoparticles advance beyond the liver, developers across RNA, cell, and gene industries are re-evaluating their strategies to address payload delivery challenges. This is driving new innovations, novel chemistries and methods to improve toxicity profiles, potency and efficacy, while ensuring manufacturability at scale. This interactive workshop will explore the scientific, technical, and regulatory trade-offs shaping the future of extrahepatic LNP delivery.
Join this discussion to gain key insights on:
- Exploring novel LNP and nanoparticle targeting strategies from receptor targeting, antibody conjugation and organ-selective platforms to improve biodistribution, target specificity, and improve therapeutic efficacy
- Assessing the CMC and manufacturing challenges of complex LNP formulations to ensure stability and delivery efficiency
- Delving into toxicology and pharmacology of targeting moieties, potential biological interference, and exploring practical considerations for regulatory approval of targeted LNP system
12:00 pm Lunch Break
12:45 pm Networking Break
This networking session is your opportunity to get face-to-face with many of the brightest minds working in the mRNA, cell and gene fields and establish meaningful business relationships to pursue for the rest of the conference.
Workshop B – Manufacturing
1:30 pm Accelerating mRNA Process Development & Manufacturing Strategies to Improve Quality, Analytics & Regulatory Harmonization for New mRNA Product Development
With the rise of complexity in mRNA modalities as an application or tool, now better innovations and approaches are now required to ensure scalable manufacturing and CMC process towards the clinic. This workshop will dive into new CMC and regulatory pathways to go from drug substance to final product with new processes, strategies, and manufacturing insights across the Asia-Pacific Region.
Join this discussion to gain key insights on:
- From Lab to GMP: Practical strategies for accelerating mRNA process development, quality control and regulatory alignment – Insights from Australia’s end-to-end RNA ecosystem
- CMC and regulatory strategies for self-amplifying mRNA vaccine manufacturing in Japan
- Technical process development and CMC scale-up strategies – Real-world approaches to accelerating mRNA manufacturing while maintaining quality and analytics robustness for domestic production